EPIZYME INC (EPZM) Stock News
NASDAQ:EPZM - Nasdaq - US29428V1044 - Common Stock - Currency: USD
EPZM Latest News, Press Relases and Analysis
Epizyme: Q2 Earnings Insights
Epizyme (NASDAQ:EPZM) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update
SHAREHOLDER ALERT: Weiss Law Investigates Epizyme, Inc.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Epizyme, Inc....
Why Is Epizyme (EPZM) Stock Up 75% Today?
EPZM stock is jumping higher today on news that Epizyme is being acquired by French pharmaceutical company Ipsen.
Why Epizyme Shares Are Soaring Today
Epizyme Inc (NASDAQ: EPZM) shares are trading higher Monday after the company announced it entered into a definitive agreement to be acquired by Ipsen.
Shareholder Alert: Ademi LLP investigates whether Epizyme, Inc. has obtained a Fair Price in its transaction with Ipsen
/PRNewswire/ -- Ademi LLP is investigating Epizyme (NASDAQ:EPZM) for possible breaches of fiduciary duty and other violations of law in its transaction with...
Axsome Therapeutics (AXSM) Stock Soars on FDA Labeling Proposal
Axsome Therapeutics (AXSM) stock is rising higher on Monday following an update from the FDA about product labeling for one of its drugs.
EPZM Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Epizyme, Inc. Is Fair to Shareholders
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Good morning, trader! We're starting off the week with an overview of the biggest pre-market stock movers for Monday morning!
Ipsen to acquire Epizyme, expanding its portfolio in oncology
Mentions: OTC
